La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Renovaro a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Renovaro..

Renovaro (NASDAQ:RENB) Azioni, Catena delle Opzioni

Renovaro Biosciences

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Renovaro Inc

renBTC

News

Offerings

General

CNEY

CN Energy Group Files Prospectus Related To Resale, From Time To Time By Selling Shareholder, Of Up To 32M Class A Ordinary Shares

<h3>Gainers</h3>
<ul>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock increased by 8.4% to $0.25 during Monday's after-market session. The market value of their outstanding shares is at $5.3 million. </li>
<li>Dogness (Intl) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) stock increased by 7.84% to $17.6. The market value of their outstanding shares is at $406.1 million. </li>
<li>PetMed Express (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) shares rose 4.81% to $3.48. The market value of their outstanding shares is at $67.9 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) shares rose 4.77% to $0.84. The company's market cap stands at $10.6 million. </li>
<li>BARK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BARK#NYSE">BARK</a>) stock rose 4.6% to $0.92. The company's market cap stands at $149.3 million. </li>
<li>Visionary Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) stock increased by 4.31% to $1.67. The market value of their outstanding shares is at $6.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Epsium Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSM#NASDAQ">EPSM</a>) stock declined by 18.7% to $10.76 during Monday's after-market session. The market value of their outstanding shares is at $206.1 million. </li>
<li>GoPro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) shares declined by 7.18% to $0.7. The company's market cap stands at $118.3 million. </li>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) stock fell 4.97% to $0.23. The market value of their outstanding shares is at $25.0 million. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock fell 4.68% to $0.88. The company's market cap stands at $18.1 million. </li>
<li>Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) shares fell 4.59% to $3.75. The market value of their outstanding shares is at $49.2 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>Ethan Allen Interiors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETD#NYSE">ETD</a>) stock fell 4.48% to $26.61. The market value of their outstanding shares is at $710.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BARK

CULP

DOGZ

EPSM

GDHG

GORV

GPRO

NAAS

PETS

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) shares moved upwards by 14.2% to $0.73 during Monday's after-market session. The market value of their outstanding shares is at $57.0 million. </li>
<li>Telomir Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELO#NASDAQ">TELO</a>) stock increased by 10.39% to $1.38. The market value of their outstanding shares is at $45.5 million. </li>
<li>Shattuck Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STTK#NASDAQ">STTK</a>) shares rose 8.61% to $0.86. The market value of their outstanding shares is at $40.8 million. </li>
<li>Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) shares moved upwards by 8.25% to $7.7. The market value of their outstanding shares is at $14.3 million. </li>
<li>Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) shares moved upwards by 7.8% to $0.35. The market value of their outstanding shares is at $13.8 million. </li>
<li>Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) shares rose 6.72% to $0.32. The market value of their outstanding shares is at $36.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares decreased by 10.5% to $4.61 during Monday's after-market session. The market value of their outstanding shares is at $2.5 million. </li>
<li>Xenetic Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XBIO#NASDAQ">XBIO</a>) shares fell 10.18% to $3.53. The company's market cap stands at $5.4 million. </li>
<li>Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) shares fell 8.62% to $8.7. The company's market cap stands at $1.0 billion. </li>
<li>Axogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) stock declined by 7.75% to $10.01. The market value of their outstanding shares is at $478.2 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares fell 7.01% to $1.46. The company's market cap stands at $5.5 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) shares declined by 6.78% to $0.23. The market value of their outstanding shares is at $2.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

APDN

AXGN

CLRB

MLSS

MRSN

RLYB

STTK

TELO

VTAK

XBIO

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>PS International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) stock rose 10.2% to $0.43 during Monday's after-market session. The company's market cap stands at $9.8 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) stock moved upwards by 8.04% to $0.94. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock increased by 6.96% to $3.53. The company's market cap stands at $119.4 million. </li>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) stock moved upwards by 6.07% to $5.24. The company's market cap stands at $34.5 million. </li>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) shares increased by 5.76% to $3.85. The company's market cap stands at $82.2 million. </li>
<li>FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) stock rose 5.42% to $0.68. The company's market cap stands at $5.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares declined by 13.0% to $0.1 during Monday's after-market session. The market value of their outstanding shares is at $1.9 million. </li>
<li>AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) stock fell 7.5% to $263.6. The company's market cap stands at $12.7 billion. The company's, Q4 earnings came out 4 days ago. </li>
<li>Concorde Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) shares fell 6.87% to $13.7. The company's market cap stands at $214.7 million. </li>
<li>Eshallgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHGO#NASDAQ">EHGO</a>) stock decreased by 6.33% to $0.74. The company's market cap stands at $22.0 million. </li>
<li>ADS-TEC Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSE#NASDAQ">ADSE</a>) stock decreased by 6.24% to $12.94. The market value of their outstanding shares is at $727.7 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) shares declined by 6.07% to $0.53. The market value of their outstanding shares is at $9.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSE

AVAV

CIGL

EHGO

GLXG

JVSA

JVSAR

KSCP

NEOV

PSIG

12 Industrials Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock rose 21.1% to $7.13 during Monday's after-market session. The company's market cap stands at $9.5 million. </li>
<li>BitMine Immersion Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) stock moved upwards by 20.35% to $40.8. The company's market cap stands at $25.8 million. </li>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) shares increased by 12.76% to $0.27. The market value of their outstanding shares is at $13.8 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock increased by 8.28% to $0.2. The company's market cap stands at $23.1 million. </li>
<li>Fatpipe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATN#NASDAQ">FATN</a>) shares increased by 5.69% to $10.4. The company's market cap stands at $107.0 million. </li>
<li>QuickLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUIK#NASDAQ">QUIK</a>) stock increased by 4.87% to $6.46. The company's market cap stands at $100.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) shares decreased by 10.3% to $8.94 during Monday's after-market session. The company's market cap stands at $62.8 million. As per the press release, Q4 earnings came out today. </li>
<li>908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) stock declined by 7.15% to $6.62. The company's market cap stands at $241.3 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares decreased by 5.65% to $1.16. The market value of their outstanding shares is at $4.1 million. </li>
<li>Methode Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) shares decreased by 4.95% to $9.04. The market value of their outstanding shares is at $337.9 million. </li>
<li>Rimini Street (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMNI#NASDAQ">RMNI</a>) shares declined by 4.64% to $3.6. The market value of their outstanding shares is at $342.7 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares declined by 4.62% to $0.15. The market value of their outstanding shares is at $37.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARBK

BMNR

CLRO

FATN

MASS

MYSZ

QMCO

QUIK

RMNI

TDTH

12 Information Technology Stocks Moving In Monday's After-Market Session

Central Pacific Financial Files For Mixed Shelf Of Up To $300M

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">9</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.8, a high estimate of $194.00, and a low estimate of $114.00. A 10.3% drop is evident in the current average compared to the previous average price target of $152.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1751317261_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive KKR is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$140.00</td>
<td>$136.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$120.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$141.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$136.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$131.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Vikram Gandhi</td>
<td>HSBC</td>
<td>Lowers</td>
<td>Buy</td>
<td>$119.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$114.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$129.00</td>
<td>$181.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$126.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$120.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Chris Allen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$132.00</td>
<td>$177.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$194.00</td>
<td>$214.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to KKR. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of KKR compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of KKR's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into KKR's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KKR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on KKR analyst ratings.</a>
<h2>All You Need to Know About KKR</h2>
KKR is one of the world's largest alternative asset managers, with $664.3 billion in total managed assets, including $526.0 billion in fee-earning AUM, at the end of March 2025. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
<h3>KKR's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: KKR's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -68.18%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: KKR's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -6.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): KKR's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.82%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): KKR's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.05%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.04, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

15 Analysts Assess KKR: What You Need To Know

4 analysts have shared their evaluations of Expeditors International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPD#NYSE">EXPD</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $109.25, a high estimate of $117.00, and a low estimate of $105.00. Observing a downward trend, the current average is 3.53% lower than the prior average price target of $113.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1751317221_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Expeditors International among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lucas Servera</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$110.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Thomas Wadewitz</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$117.00</td>
<td>$128.00</td>
</tr>
<tr>
<td>Brandon Oglenski</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Lucas Servera</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Expeditors International. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Expeditors International compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Expeditors International's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Expeditors International's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EXPD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Expeditors International analyst ratings.</a>
<h2>All You Need to Know About Expeditors International</h2>
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.
<h3>Financial Insights: Expeditors International</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3M period, Expeditors International showcased positive performance, achieving a revenue growth rate of 20.83% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Expeditors International's net margin excels beyond industry benchmarks, reaching 7.64%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Expeditors International's ROE excels beyond industry benchmarks, reaching 9.04%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Expeditors International's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.29% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Expeditors International's debt-to-equity ratio is below the industry average at 0.26, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXPD

4 Analysts Assess Expeditors International: What You Need To Know

In the current market session, Kodiak Gas Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) share price is at $34.27, after a 0.76% spike. Moreover, over the past month, the stock decreased by 6.44%, but in the past year, went up by 25.85%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1751317217_0.png" alt="Past Year Chart" />

<h3>Comparing Kodiak Gas Services P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 18.37 in the Energy Equipment &amp; Services industry, Kodiak Gas Services Inc. has a higher P/E ratio of 68.02. Shareholders might be inclined to think that Kodiak Gas Services Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751317217_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Kodiak Gas Services

Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) has outperformed the market over the past 15 years by 4.85% on an annualized basis producing an average annual return of 17.55%. Currently, Extra Space Storage has a market capitalization of $31.29 billion. 
Buying $1000 In EXR: If an investor had bought $1000 of EXR stock 15 years ago, it would be worth $11,306.75 today based on a price of $147.44 for EXR at the time of writing.
<h3>Extra Space Storage's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751317213_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Extra Space Storage 15 Years Ago Would Be Worth Today

On June 24, 2025, InMed Pharmaceuticals Entered Agreement To Sell 1.9M Shares At $2.561 Each

Nixxy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>), a next-generation communications company integrating AI-driven technologies into telecom infrastructure, announced today that it has been added to the Russell 3000E&#xAE; Index, effective at the conclusion of the annual reconstitution of the Russell US Indexes. <a href="https://pr.report/bylt">https://www.lseg.com/content/dam/ftse-russell/en_us/documents/other/rmicro-additions-20250523.pdf</a>. The index is reconstituted annually to reflect changes in the U.S. markets over the past year.
The Russell 3000E&#xAE; Index represents the broadest U.S. equity index, combining the Russell 3000&#xAE; Index with the Russell Microcap&#xAE; Index. The index includes up to 4,000 of the largest U.S. stocks by total market capitalization, providing investors with comprehensive exposure to the investable U.S. equity market. The Russell US Indexes are widely used by investment managers and institutional investors for index funds, benchmarking, and ETF development.

NIXX

Nixxy Inc. Announces It Has Been Added To The Russell 3000E Index

HWBK

Hawthorn Bancshares To Be Added To Russell 3000 and Russell 2000 Indexes

Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) shares rose heading into Monday&#8217;s closing bell following a report that the company is exploring the use of artificial intelligence technology from Anthropic or OpenAI to power an updated <a href="https://www.benzinga.com/markets/tech/25/06/46162539/apples-biggest-mistake-ex-nokia-and-tesla-engineer-explains-whats-really-going-wrong">version of Siri. </a>
What To Know: Apple held discussions with both Anthropic and OpenAI about integrating their large language models into Siri and has requested that these models be adapted to run on Apple's cloud infrastructure for testing purposes, according to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-06-30/apple-weighs-replacing-siri-s-ai-llms-with-anthropic-claude-or-openai-chatgpt?embedded-checkout=true">report</a>. 
Read Next: <a href="https://www.benzinga.com/markets/tech/25/06/46130084/cathie-woods-alpha-surge-250-million-circle-windfall-big-amd-buys?utm_source=articleShare">Cathie Wood&#8217;s Alpha Surge: $250 Million Circle Windfall, Big AMD Buys</a>
The review of external models was initiated by Siri Chief Mike Rockwell and Software Engineering Head Craig Federighi, who took over Siri after John Giannandrea was reassigned due to slow progress on Apple Intelligence and Siri upgrades.
Rockwell's team has tested various models, including those from Anthropic, OpenAI and Google, and found Anthropic's technology to be the most promising for Siri's requirements. This led to further talks with Anthropic about using its Claude model, according to the report. 
The evaluation of third-party AI models is still in the early stages, and no final decision has been made. Apple continues to develop an internal project called LLM Siri, which uses its own models. 
However, the possibility of adopting external AI is being considered for next year, which could help Siri match the capabilities of more advanced AI assistants and improve Apple's standing in the AI sector.
AAPL Price Action: Apple shares ended Monday&#8217;s session 2.03% higher at $205.17, according to data from Benzinga Pro. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46117473/sofi-stock-gets-supercharged-with-return-to-crypto?utm_source=articleShare">SoFi Stock Gets Supercharged With Return To Crypto</a></li>
</ul>
Image: Shutterstock&nbsp;

Large Cap

Tech

AAPL

What Happened With Apple Stock Today?

Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares are getting a slight bump in after-hours trading Monday after the company announced a<a href="https://www.benzinga.com/pressreleases/25/06/n46181263/boeing-announces-chief-financial-officer-transition-plan"> CFO transition plan</a>.
What Happened: After the market close on Monday, Boeing announced that Jesus &#8220;Jay&#8221; Malave has been elected as incoming executive vice president and CFO. Current CFO Brian West, who has been CFO for the past four years, will transition to become a senior advisor to Boeing President and CEO Kelly Ortberg.
&#8220;These past few years have been some of the most consequential in Boeing&#8217;s history, and Brian successfully guided us through last year&#8217;s historic capital raise and ensured our team always had the resources to continue the critical work to strengthen safety and quality across our operations. I look forward to his continued counsel in his new role,&#8221; Ortberg said.
Malave, who is the former CFO of Lockheed Martin and L3Harris, will lead Boeing&#8217;s financial strategy, reporting, long-range business planning and investor relations. 
The news comes after Boeing shares fell about 2.32% during Monday&#8217;s regular session following reports U.K. antitrust regulators launched a <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46180869/whats-going-on-with-boeing-shares-today-5">formal investigation</a> into the company&#8217;s planned $4.7 billion acquisition of fuselage maker Spirit AeroSystems.
In July 2024, Boeing signed a deal to acquire Spirit, which has been at the center of quality concerns related to the company&#8217;s 737 Max
BA Price Action: <a href="http://benzinga.com/quote/BA">Boeing shares</a> were down 0.014% in Monday&#8217;s after-hours session, trading at $209.50 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/06/46174414/stock-of-the-day-will-boeing-prove-an-old-wall-street-saying-is-true">Stock Of The Day: Will Boeing Prove An Old Wall Street Saying Is True?</a></li>
</ul>
Photo: Shutterstock.

Management

Boeing Announces CFO Transition, Shares Volatile After Hours

Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) has outperformed the market over the past 10 years by 7.93% on an annualized basis producing an average annual return of 19.44%. Currently, Waste Connections has a market capitalization of $48.25 billion. 
Buying $1000 In WCN: If an investor had bought $1000 of WCN stock 10 years ago, it would be worth $5,936.41 today based on a price of $186.72 for WCN at the time of writing.
<h3>Waste Connections's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751316311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

NASA and streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) announced a new partnership Monday that could give<a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering"> viewers more options</a> to see live rocket launches, including those from Elon Musk's SpaceX.
What Happened: NASA announced Monday that its NASA+ live programming will be made available on Netflix, creating a bigger spotlight for the space sector.
"The National Aeronautics and Space Act of 1958 calls on us to share our story of space exploration with the broadest possible audience," NASA+ general manager Rebecca Sirmons <a href="https://www.nasa.gov/news-release/nasa-is-coming-to-netflix-this-summer/?utm_source=TWITTER&amp;utm_medium=NASA&amp;utm_campaign=NASASocial&amp;linkId=835859747">said</a>.
Sirmons said NASA and Netflix are committed to a "Golden Age of Innovation and Expansion" that could inspire new generations.
The new content will consist of streaming live rocket launches, astronaut spacewalks, "breathtaking live views of Earth" from the International Space Station and space mission coverage.
Musk shared news on the partnership, retweeting both a NASA tweet and a Netflix tweet on the same topic.
SpaceX remains one of the largest space companies and has completed the most rocket launches in 2025, making it the only U.S. company currently capable of transporting astronauts to and from the International Space Station.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/05/38550496/elon-musk-says-he-has-not-watched-emmy-nominated-documentary-about-his-ambitious-space-plan">Elon Musk Says He Has Not Watched Emmy-Nominated Documentary About His Ambitious Space Plans: &#8216;Haven&#8217;t Seen It Yet&#8217;</a>
Why It's Important: The partnership with Netflix could put NASA content in front of millions more people worldwide. A press release stated that Netflix has a global audience of over 700 million people.
NASA hopes the partnership will help bring excitement to space exploration in the future.
While Netflix users will have access to the new NASA programming, users outside the platform will also be able to view the content for free in other places.
"Our NASA+ streams and live events will continue to be available on <a href="http://plus.nasa.gov">http://plus.nasa.gov</a>, as well as our YouTube channel and other social platforms," NASA <a href="https://x.com/NASA/status/1939731966699413883">tweeted</a>.
With ambitious plans to send people to Mars in the future, Musk's SpaceX could become a key to space-related content used by NASA and Netflix.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/entertainment/25/06/46176403/elon-musk-donald-trump-inspired-these-squid-game-characters-the-ones-running-everything-the-ones-in-control">Elon Musk, Donald Trump Inspired These &#8216;Squid Game&#8217; Characters: &#8216;The Ones Running Everything… The Ones In Control&#8217;</a></li>
</ul>
Image created using photos from Shutterstock.

Entertainment

SPACE

NFLX

Elon Musk Wants You To Stream Rocket Launches: Here's How To Get 'Breathtaking Live Views Of Earth'

Generation Income Properties, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIPR#NASDAQ">GIPR</a>) ("GIPR" or the "Company"), a net lease real estate investment trust focused on strategically located, primarily investment-grade single-tenant assets, today provided a business update, including details on recent transactions, operational performance, recapitalization efforts, and the ongoing strategic alternatives process.
Recent Transaction Activity and Financial Progress
In May 2025, GIPR completed the sale of two (2) properties, the Auburn University occupied industrial building in Huntsville, AL and a Starbucks occupied building in Tampa, FL, representing a combined gross sale price of approximately $10.5 million, at cap rates of 4.06% or $121.64 per square foot and 5.82% or $1,568.18 per square foot, respectfully. Proceeds from these sales were used to pay off approximately $10.5 million in debt. GIPR's motivation for these sales was twofold.
GIPR determined that the assets were at their highest value, given current market conditions, and it was an opportunity to realize the liquidity of the assets.
GIPR wanted to completely pay off the one CMBS loan on its balance sheet with the proceeds of these two properties, which left the Company with one property, the 7-Eleven in Washington, DC, completely unencumbered. In June 2025, GIPR received a new loan in the amount of approximately 50% of the value of the 7-Eleven property (approximately $750,000) from its primary lender, Valley National Bank.
These actions align with GIPR's ongoing strategy to strengthen the balance sheet and preserve long-term shareholder value amid a challenging capital markets environment.
Macroeconomic Headwinds and REIT Market Conditions
Management acknowledged that elevated interest rates, limited access to public equity capital, and compressed trading multiples have created significant headwinds for small, publicly traded REITs. Despite these market challenges, GIPR's real estate portfolio continues to demonstrate strong tenant credit quality, 100% rent collection, geographic diversity, and stable cash flows. Recapitalization/Refinance Efforts Underway
As GIPR continues its efforts to enhance financial flexibility and reduce capital market dependency, it is pursuing several recapitalization strategies, which may include:
Refinancing and recapitalizing all or portions of its preferred equity in its GIP VB SPE, LLC subsidiary and/or its asset-level debt
Asset-level debt placements on select properties
Exploration of strategic equity capital partnerships at the subsidiary level
Strategic Alternatives Process
As previously announced, GIPR's Special Committee initiated a formal review of strategic alternatives, and in connection with such formal review, the Special Committee recently executed an engagement letter with Cantor Fitzgerald &amp; Co. to evaluate a full range of potential outcomes. These may include, but are not limited to:
A merger or strategic combination
A recapitalization or go-private transaction
A joint venture or other strategic capital partnership
A potential sale of the company
Or a continuation as a public REIT under an optimized structure
No assurances can be given regarding the outcome or timing of this review, and GIPR does not intend to comment further unless or until the Board has approved a specific course of action or the process concludes.

GIPR

Generation Income Properties Sells $10.5M In Assets To Pay Off Debt, Secures New Loan, And Pursues Strategic Alternatives Including Merger, Recapitalization, Joint Venture, Sale, Or Optimized Public REIT Structure

ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) today announced that its Board of Directors has declared a one-time special stock dividend on the Company's issued and outstanding shares of common stock, par value $0.001 per share (the "Common Stock"), and any Common Stock equivalents with dividend rights (the "Common Stock Equivalents"), to provide its legacy stockholders with a 100% stake in the proceeds from any eventual sale of all or substantially all of the Company's current assets and operations in one or more transactions (collectively, the "Asset Sale").
This Special Stock Dividend is part of the Company's ongoing strategic process and in support of its previously disclosed plan to pursue one or more transactions, including the Asset Sale, and involves issuing to holders of Common Stock and Common Stock Equivalents one share of the Company's Class A Redeemable Preferred Stock, par value $0.001 per share (the "Class A Preferred Stock"), for every issued and outstanding share of Common Stock and Common Stock Equivalent. Upon the completion of any Asset Sale, which may occur in one or a series of transactions, the Class A Preferred Stock shall be redeemed by the Company for 100% of the net proceeds of any such Asset Sale.
The Special Stock Dividend will be payable on July 18, 2025 to stockholders of record as of July 11, 2025. Because the Special Stock Dividend exceeds twenty-five percent (25%) of the value of the Common Stock, in accordance with FINRA UPC (Uniform Practice Code) Rule 11140, a stockholder of the Company that sells shares of Common Stock on or prior to the payment date of July 18, 2025 will not receive the Special Stock Dividend for the shares of Common Stock that are sold.

Dividends

ClearOne Declares One-Time Special Stock Dividend On The Co's Issued And Outstanding Shares Of Common Stock And Any Common Stock Equivalents With Dividend Rights To Legacy Stockholders With A 100% Stake In The Proceeds From Any Eventual Sale Of All Or Substantially All Of The Co's Current Assets And Operations In One Or More Transactions

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.67 per share. This is a 297.06 percent increase over losses of $(0.34) per share from the same period last year. The company reported $9.584 million in sales this quarter. This is a 7.55 percent increase over sales of $8.911 million the same period last year.

Earnings

ELLO

Ellomay Capital Q1 EPS $0.67 Up From $(0.34) YoY, Sales $9.584M Up From $8.911M YoY

Press Releases

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Health Care

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

Legal

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Small Cap

Opinion

AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Smart Healthcare Is Taking Over. Here's Where the Money's Headed

Biotech

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

AMZN

AVAI

CCLD

CCLDO

CERT

GOOG

GOOGL

MSFT

OMDA

POAI

RENB

TREN

ABVC BioPharma

Adicet Bio

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Ainos

Aligos Therapeutics

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Avalo Therapeutics

Celularity

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

CervoMed

Cue Biopharma

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Fortress Biotech

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

MAIA Biotechnology

Metagenomi

OS Therapies

PMV Pharma

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Renovaro

RenovoRx

Senti Biosciences

Screenshot 2024-05-06 at 6.05.33 PM

NVDA

Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection

Comments

Renovaro

Renovaro (RENB) Opzioni

Renovaro (NASDAQ:RENB) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO